Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Merck Sharp & Dohme LLC
Verastem, Inc.
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Pfizer
M.D. Anderson Cancer Center
Providence Health & Services
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
Trishula Therapeutics, Inc.
SWOG Cancer Research Network
Fox Chase Cancer Center
EpicentRx, Inc.
Sun Yat-sen University
Actuate Therapeutics Inc.
BeiGene
National Cancer Institute (NCI)
Spanish Lung Cancer Group
Canadian Cancer Trials Group
Wake Forest University Health Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
AIO-Studien-gGmbH
Intergroupe Francophone de Cancerologie Thoracique
Northwestern University
Case Comprehensive Cancer Center
Hoosier Cancer Research Network
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
CTI BioPharma
Guangzhou Institute of Respiratory Disease
SWOG Cancer Research Network
Eli Lilly and Company
Incyte Corporation
Celgene
Swiss Cancer Institute
Mayo Clinic
Shanghai University of Traditional Chinese Medicine
Guangdong Association of Clinical Trials
Wake Forest University Health Sciences